Natural merodiploidy involving duplicated rpoB alleles affects secondary metabolism in a producer actinomycete.
Actinomadura sp. ATCC 39727 produces the glycopeptide antibiotic A40926, structurally similar to teicoplanin. Production of A40926 is governed by the stringent response at the transcriptional level. In fact, addition of an amino acid pool prevented the transcription of dbv cluster genes involved in the A40926 biosynthesis and the antibiotic production in chemically defined media, and a thiostrepton-resistant relaxed mutant was severely impaired in its ability to produce the antibiotic. The derivative strain rif19, highly resistant to rifampicin (minimal inhibitory concentration, MIC > 200 microg ml(-1)), was isolated from the wild type strain that exhibited low resistance to rifampicin (MIC < 25 microg ml(-1)). In this strain A40926 production started earlier than in the wild type, and reached higher final levels. Moreover, the antibiotic production was not subjected to the stringent control. Molecular analysis led to the identification of two distinct rpoB alleles, rpoBS and rpoBR, in both the wild type and the rif19. rpoBR harboured the H426N missense which is responsible for rifampicin-resistance in bacteria, in addition to other nucleotide substitutions affecting the primary structure of the RNA polymerase beta-chain. Transcript analysis revealed that rpoBR was expressed at a very low level in the wild type strain during the pseudo-exponential growth phase, and that the amount of rpoBR mRNA increased during the transition to the stationary phase. In contrast, expression of rpoBR was constitutive in the rif19. The results of mRNA half-life analysis did not support the hypothesis that post-transcriptional events are responsible for the different rpoB expression patterns in the two strains, suggesting a role of transcriptional mechanisms.
Vigliotta
Giovanni
G
Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università degli Studi di Lecce, Via Monteroni, 73100 Lecce, Italy.
Tredici
Salvatore Maurizio
SM
Damiano
Fabrizio
F
Montinaro
Maria Rosa
MR
Pulimeno
Rita
R
di Summa
Roberta
R
Massardo
Domenica Rita
DR
Gnoni
Gabriele V
GV
Alifano
Pietro
P
D000192:Actinomycetales / Q000187:drug effects / Q000235:genetics / Q000254:growth & development* / Q000378:metabolism; D000483:Alleles; D000595:Amino Acid Sequence; D000900:Anti-Bacterial Agents / Q000096:biosynthesis*; D003470:Culture Media; D012321:DNA-Directed RNA Polymerases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D004171:Diploidy; D024881:Drug Resistance, Bacterial; D020440:Gene Duplication; D015964:Gene Expression Regulation, Bacterial; D008969:Molecular Sequence Data; D012293:Rifampin / Q000494:pharmacology; D017334:Teicoplanin / Q000031:analogs & derivatives; D013883:Thiostrepton / Q000494:pharmacology; D014158:Transcription, Genetic
C054981:A 40926; D000900:Anti-Bacterial Agents; D003470:Culture Media; D017334:Teicoplanin; D012321:DNA-Directed RNA Polymerases; C105078:RNA polymerase beta subunit; D013883:Thiostrepton; D012293:Rifampin